Therapeutic potential of selective modulators of nuclear receptor action

https://doi.org/10.1016/S1367-5931(98)80126-9Get rights and content

Abstract

Nuclear receptors belong to a superfamily of ligand-inducible transcription factors that, in addition to directly regulating their cognate gene programs, can also mutually interfere with other signaling pathways. The recent identification of selective agonists/antagonists of the glucocorticoid, retinoid and estrogen receptors suggests that it might be possible to selectively elicit only a subset of the nuclear receptor functions that are induced by the natural ligand, with the aim of increasing the functional and, perhaps, tissue selectivity of nuclear receptor ligands and reducing unwanted side effects.

References (57)

  • Y Kamei et al.

    A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptor

    Cell

    (1996)
  • HM Reichardt et al.

    Dimerization of the glucocorticoid receptor is not essential for survival (of outstanding interest)

    Cell

    (1998)
  • JY Chen et al.

    Two distinct actions of retinoid-receptor ligands

    Nature

    (1996)
  • M Kizaki et al.

    Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro

    Blood

    (1996)
  • G Giannini et al.

    Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells

    J Biol Chem

    (1997)
  • GJM Kuiper et al.

    The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens

    FEBS Lett

    (1997)
  • W Bourguet et al.

    Crystal structure of the ligand binding domain of the human nuclear receptor RXR alpha

    Nature

    (1995)
  • J-P Renaud et al.

    Crystal structure of the RARγ ligand binding domain bound to all-trans retinoic acid

    Nature

    (1995)
  • RL Wagner et al.

    A structural role for hormone in the thyroid hormone receptor

    Nature

    (1995)
  • AM Brzozowski et al.

    Molecular basis of agonism and antagonism in the oestrogen receptor (of outstanding interest)

    Nature

    (1997)
  • J-M Wurtz et al.

    A canonical structure for the ligand-binding domain of nuclear receptors

    Nat Struct Biol

    (1996)
  • JD Chen et al.

    A transcriptional co-repressor that interacts with nuclear hormone receptors

    Nature

    (1995)
  • JJ Voegel et al.

    The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways (of special interest)

    EMBO J

    (1998)
  • E Kalkhoven et al.

    Isoforms of steroid receptor coactivator 1 differ in their ability to potentiate transcription by estrogen receptor (of special interest)

    EMBO J

    (1998)
  • XF Ding et al.

    Nuclear receptor binding sites of coactivators glucocorticoid receptor interacting protein 1(GRIP1) and steroid receptor coactivator 1(SRC1): multiple motifs with different binding specificities

    Mol Endocrinol

    (1998)
  • J Wong et al.

    Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation

    EMBO J

    (1997)
  • JD Fondell et al.

    Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex

    Proc Nat Acad Sci USA

    (1996)
  • AJ Hörlein et al.

    Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

    Nature

    (1995)
  • Cited by (67)

    • Retinoic acid receptors: From molecular mechanisms to cancer therapy

      2015, Molecular Aspects of Medicine
      Citation Excerpt :

      The inhibition of AP-1 activity by RAR/RXR association involves the expression of several genes such as those of osteocalcin, stromelysin and collagenase (Schüle et al., 1990). As for Stat5 and ERα, close regulatory regions for both RARs and AP-1 have been reported in their gene promoters (Germain et al., 2006a; Lafyatis et al., 1990; Nicholson et al., 1990; Resche-Rigon and Gronemeyer, 1998; Schüle et al., 1990). RARs can exert both genomic and non-genomic effects.

    • CAC1 negatively regulates RARα activity through cooperation with HDAC

      2012, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      NRs including RAR are ligand-inducible transcription factors that specifically regulate the expression of target genes. All NRs share a common modular structure consisting of an N-terminal transcriptional activation domain (AF-1), a conserved DNA-binding domain (DBD), a hinge region (D), and a C-terminal ligand-binding domain (LBD) that overlaps with the second transcriptional activation domain (AF-2) [1,2,4]. Retinoid signaling is generated by two families of nuclear receptors, the RAR and retinoid X receptor (RXR), which bind as RAR/RXR heterodimers to cis-acting RA response elements (RAREs) located in the regulatory sequences of target genes [5].

    View all citing articles on Scopus
    View full text